SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of Report (Date Earliest Event Reported) December 10, 2004
-----------------
BIOSYNERGY, INC.
-----------------------------------------------------
(Exact name of Registrant as specified in its charter)
Illinois 0-12459 36-2880990
- ----------------------------- ---------------- ---------------------
(State or other jurisdiction (Commission (IRS Employer
or incorporation) File Number) Identification)
1940 E. Devon, Elk Grove Village, Illinois 60007
----------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (847) 956-0471
---------------
N/A
- ----------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry Into a Material Definitive Agreement
------------------------------------------
On December 10, 2004, Biosynergy, Inc. (the "Company") entered into
an agreement to extend the Stock Option Agreement between Fred K.
Suzuki, President, and the Company, dated November 12, 2001 (the
"Stock Option Agreement") by amending the Stock Option Agreement.
The Stock Option Agreement was originally entered into on November
12, 1998 and extended to November 12, 2001 with respect to the
unexercised portion of the option. Effective November 12, 2004, the
Company further extended the Option Agreement for two years to
November 12, 2006 with respect to the remaining unexercised portion,
or 2,591,000 shares. The option price for these shares is $.025 per
share.
Item 9.01. Financial Statements and Exhibits
----------------------------------
(c) Exhibits
(10) Material Contracts
(i) Amended Stock Option Agreement, dated
November 12, 2004, between the Company and
Fred K. Suzuki
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOSYNERGY, INC.
Date: _______, 2004 By: /s/ Fred K. Suzuki /s/
---------------------------------
Fred K. Suzuki, President
By: /s/ Lauane C. Addis /s/
---------------------------------
Lauane C. Addis, Secretary